GAMT p.Arg63=
c.189G>C · rs568392459 · VCV288963
ClinGen expert panel — Cerebral Creatine Deficiency Syndromes VCEP
Likely Benign for guanidinoacetate methyltransferase deficiency. Applied ACMG criteria (verbatim):
BP7 BP4
Curation rationale (ClinGen, verbatim)
The NM_000156.6:c.189G>C (p.Arg63=) variant in GAMT is a synonymous (silent) variant that is not predicted by SpliceAI to impact splicing. In addition, it occurs at a nucleotide that is not conserved as shown by phyloP (score -1.308) (BP4, BP7). To our knowledge, this variant has not been reported among individuals with GAMT deficiency and results of functional studies are unavailable. The highest population minor allele frequency in gnomAD v4.1.0 is 0.0004955 (3/6054) in the Middle Eastern population. This is higher than the ClinGen CCDS VCEP's threshold for PM2_Supporting (<0.0004), and lower than the threshold for BS1 (>0.001). Therefore, no population criteria are met. There is a ClinVar entry for this variant (Variation ID: 288963). In summary, this variant meets the criteria to be classified as likely benign for GAMT deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen Cerebral Creatine Deficiency Syndromes Variant Curation Expert Panel (Specifications Version 2.0.0): BP4, BP7. (Classification approved by the ClinGen Cerebral Creatine Deficiency Syndromes Variant Curation Expert Panel on May 20, 2025).
ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Splicing | ||
| SpliceAI | <0.2 | no splice effect predicted · four deltas, not one · how we know |
|---|---|---|
| Constraint at this position | ||
| Conservation | phyloP -3.2 | GERP -3.1 |
| Overall | ||
| CADD | 4.583 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Middle Easterngrpmax | 0.0496% | 2,018 |
| African / African-American | 0.0347% | 2,884 |
| Remaining individualsnot grpmax-eligible | 0.00482% | 20,754 |
| South Asian | 0.00223% | 44,931 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- GAMT
- Protein
- p.Arg63=
- Coding
- c.189G>C
- MANE Select
- NM_000156
- dbSNP
- rs568392459
- Type
- single nucleotide variant
- Location
- chr19:1399931 (GRCh38)
- Gene constraint
- LOEUF 1.536 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Structure
- AlphaFold pLDDT 96.73 · 1 PDB
- Residue 63
- the rmt2 domain; a β-strand
Disease context
guanidinoacetate methyltransferase deficiency — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: cerebral creatine deficiency syndrome
For Guanidinoacetate methyltransferase deficiency (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Childhood, Infancy
Similar variants
- GAMT p.Arg63Trp Uncertain significance ★★ ⚠ same residue
- GAMT p.Arg63Gln Uncertain significance ★ ⚠ same residue
- GAMT p.Arg63fs Likely pathogenic ★ same residue
- GAMT c.327+43G>A Likely pathogenic ★★★ same condition
- GAMT c.328-1G>A Pathogenic ★★★ same condition
- GAMT c.328-2A>G Pathogenic ★★★ same condition
- GAMT c.391+15G>T Likely pathogenic ★★★ same condition
- GAMT c.391+1G>C Pathogenic ★★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/gamt-p-arg63 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown